local anesthetic drug
Scope
Date
~
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Sovereign bonds
S.Korean institutional investors inject more capital in MMFs
South Korean institutional investors, such as pension funds, mutual aids and corporates, are rushing to money market funds (MMFs) for short-term pro...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Earnings
Meritz Securities poised to become Korea’s No. 1 for first time
Meritz Securities Co., once a mid-tier securities firm in South Korea, is expected to command the local market as No. 1 after earning more than 1 tr...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha kickstarts localization of 1,000-hp gas turbine engine components
A project to lengthen the lifecycle of 1,000-horsepower gas turbine engine core components and materials, which is led by Hanwha Aerospace Co. locat...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Korean Investors
Korea Exchange acquires market operator license in Singapore
Korea Exchange (KRX) on Thursday said it has received a "Recognized Market Operator" (RMO) license from the Monetary Authority of Singapore (MAS), a...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's K-CAB to get insurance benefits in China
South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax to make inroads into Japanese market in earnest
Cosmax Inc., South Korea's cosmetics original design manufacturing (ODM) company, said on Thursday that it would start targeting the Japanese market...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong accelerates investment in CDMO business
Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...
Jan 18, 2023 (Gmt+09:00)
-
Cloud computing
Bespin Global establishes Vietnam Tech Center for cloud, digital innovation
South Korea's cloud management company Bespin Global will foster cloud and digital innovation industries in Central Vietnam. To this end, the compan...
Jan 17, 2023 (Gmt+09:00)
-
Banking & Finance
Kookmin Card acquires Cambodian leasing firm at $5.2 mn
KB Kookmin Card, a credit card unit of KB Financial Group, and its Cambodian local subsidiary KB Daehan Specialized Bank, acquired the Southeast Asi...
Jan 13, 2023 (Gmt+09:00)
-
Foreign exchange
S.Korea to extend trading hours of local forex market
South Korea will extend the trading hours for the local foreign exchange market to attract overseas investors and improve the trading system so that...
Jan 13, 2023 (Gmt+09:00)
-
Automobiles
Hyundai, Kia post record sales in India; to build IONIQ 5 locally
South Korea’s two leading automakers – Hyundai Motor Co. and Kia Corp. – are solidifying their presence in India, a fast-growing A...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Venture capital
Smart Study Venture creates $28.4 million Baby Shark Tourism Fund
Smart Study Ventures, a corporate venture capital (CVC) affiliated with The Pinkfong Company, said on Thursday that it has created a "Baby Shark Nex...
Jan 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
Korean startups win 4 out of 23 Best of Innovations at CES 2023
LAS VEGAS – South Korean startups have won four out of the 23 Best of Innovation awards from Consumer Technology Association (CTA), which host...
Jan 04, 2023 (Gmt+09:00)
-
Electric vehicles
SK Networks completes acquisition of local EV charging platform operator
SK Networks Co., a South Korean general trading firm, said on Jan. 3 it has completed the acquisition of SS Charger Co., a leading electric car char...
Jan 03, 2023 (Gmt+09:00)
Latest News
- 1 Invesco, SK D&D likely to buy co-living building in Seoul
- 2 Coupang bids for Korean luxury market dominance with Farfetch
- 3 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 4 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 5 Korea to allow non-profits to buy bad consumer loans